InMode (INMD) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Aug, 2026Executive summary
Q2 2026 GAAP revenues were $95.6 million, flat compared to Q2 2025, with stability in U.S. capital equipment and record revenue from Asia.
Consumables and service revenues grew 13% year-over-year to $22.3 million, mainly from international sales.
Management expects continued stabilization for the remainder of 2026 and is focused on long-term growth investments.
Financial highlights
Q2 2026 GAAP net income was $17.1 million ($0.29 per diluted share), down from $26.7 million ($0.42) in Q2 2025.
Non-GAAP net income was $20.8 million ($0.35 per diluted share), down from $30.1 million ($0.47) year-over-year.
GAAP gross margin declined to 75% from 80% and GAAP operating margin to 13% from 24% year-over-year.
Cash, equivalents, and short-term investments totaled $501.1 million as of June 30, 2026.
Repurchased 6.38 million shares for $87.8 million under the share repurchase program.
Outlook and guidance
FY 2026 revenue expected between $365 million and $375 million.
Non-GAAP gross margin projected at 74–76%; non-GAAP operating income between $68 million and $73 million.
Non-GAAP EPS forecasted at $1.29–$1.34.
Latest events from InMode
- Product innovation, high margins, and disciplined capital allocation drive growth amid macro headwinds.INMD
Jefferies Global Healthcare Conference9 Jul 2026 - Strong innovation and global expansion position the firm for recovery despite current headwinds.INMD
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20249 Jul 2026 - Revenue and margins fell as U.S. demand softened, but international growth and capital returns continued.INMD
Q1 20258 Jul 2026 - Revenue was $130.2M, margins declined, but new platforms gained traction amid headwinds.INMD
Q3 20248 Jul 2026 - Flat revenue outlook, margin pressure, and new products set the stage for future growth.INMD
Jefferies Global Healthcare Conference 20263 Jun 2026 - Q1 2026 revenue reached $82M with 75% gross margin and ongoing share repurchases.INMD
Q1 20266 May 2026 - Growth from new products offsets margin pressure; global expansion and R&D drive future potential.INMD
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - Manufacturing and logistics face disruption, but strategic buybacks and global expansion continue.INMD
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Flat top line expected in 2026, with new products and restructuring to drive future recovery.INMD
Barclays 28th Annual Global Healthcare Conference11 Mar 2026